811 material Form 8-K filings that 685 companies we cover made with the SEC in April 2025, each read and summarized by AI: what happened, the key figures, whether it reads positive or negative for shareholders, and how big a deal it is (impact 1-5). All of them were written later, when past filings were added: a selection, not every 8-K of the month (see the note below).
Rexford Industrial Realty's board said Chairman Richard Ziman will not stand for reelection at the 2025 annual meeting because he has decided to retire. The board will shrink to seven directors after Ziman's term ends, and the company said the retirement involves no disagreement over its operations, policies or practices.
Board determined on April 9, 2025 that Richard Ziman will not stand for reelection at the 2025 annual meeting
Ziman's retirement is his own decision, and the company says it is not the result of any disagreement with the company
Board size will decrease to seven directors effective upon the conclusion of Ziman's term following the annual meeting
AutoZone completed the sale of $500 million of 5.125% senior unsecured notes due June 15, 2030, under an underwriting agreement dated April 10, 2025. The filing adds a new direct financial obligation of that amount, with semi-annual interest payments beginning December 15, 2025.
Principal amount: $500,000,000 of 5.125% Notes due 2030, sold to underwriters led by BofA Securities, J.P. Morgan, U.S. Bancorp Investments and Wells Fargo Securities
Sale completed April 14, 2025; interest payable June 15 and December 15, starting December 15, 2025
Notes are senior unsecured, carry covenants on liens, sale and leaseback transactions and mergers, and are redeemable by the company before maturity
West Pharmaceutical Services disclosed that Cindy Reiss-Clark, its former Senior Vice President and Chief Commercial Officer and a named executive officer, left the company effective March 7, 2025. She signed a Separation Agreement and Release dated April 9, 2025, which provides one year of salary continuation and other benefits in exchange for a release of claims and continued restrictive covenants.
Departure effective March 7, 2025; role was Senior Vice President and Chief Commercial Officer
Salary continuation for one year at a salary of $489,500, plus continued welfare benefits
2025 payment of $57,526 for pro-rated Annual Incentive Plan target; outplacement services up to $15,000
Paychex completed its acquisition of Paycor HCM on April 14, 2025, under a merger agreement signed January 7, 2025. Paycor shareholders received $22.50 in cash per share, and Paychex described the deal as about $4.1 billion in enterprise value, with Paychex saying it expects the deal to be accretive to adjusted diluted EPS in fiscal 2026.
Merger completed April 14, 2025; Paycor became an indirect wholly owned subsidiary of Paychex
Paycor shares converted into the right to receive $22.50 in cash per share
Paychex expects more than $80 million in annual cost synergies in fiscal 2026 and expects the deal to be accretive to adjusted diluted EPS in fiscal 2026
Paychex will file required financial statements and pro forma information by amendment within 71 days
Roper Technologies director Christopher Wright, a director since 1991, notified the company on April 8, 2025 that he will retire from the board effective at the 2025 Annual Meeting of Shareholders on June 10, 2025. The board will shrink to 9 directors upon his retirement, and the company said his decision was not due to any disagreements on operations, policies, or practices.
Christopher Wright notified the company of his retirement on April 8, 2025
Retirement is effective at the 2025 Annual Meeting of Shareholders, to be held June 10, 2025
Board size will be reduced to 9 directors upon his retirement
Company states the retirement was not due to any disagreements with the company
StoneX signed a merger agreement on April 13, 2025 to acquire R.J. O'Brien, the futures brokerage, for an equity value the press release puts at approximately $900 million. The cash portion is $625 million, with the rest paid in StoneX common stock, and the company plans to finance the cash through capital markets transactions and committed Bank of America facilities. Shareholders face a new cash outlay, share issuance and debt, and the deal is expected to close in the second half of 2025, subject to regulatory approvals.
Merger consideration: $625 million in cash, subject to adjustment, plus StoneX common stock valued at $275 million based on a volume-weighted average price with a ceiling and floor tied to $77.50
Bank of America committed a 364-day bridge loan of up to $625 million and a backstop revolving credit facility of up to $500 million
StoneX will also assume up to $143 million of RJO debt, per the press release
Expected close in the second half of 2025, subject to regulatory approvals and customary conditions
Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.
Briefs marked “Written later” were written in November 2026 for filings that were by then more than three weeks old, so months before mid-October 2026 hold a selection: every material 8-K of the past year for the 100 largest companies we cover and the last 15 important 8-Ks of every other one. Briefs the number check holds back are not shown or counted. Also: the last 45 days, briefs by company, A–Z and the live SEC filings wire.